Nasal Spray Significantly Accelerates Respiratory Virus Clearance in Phase 2a Clinical Study
— Post hoc analyses found a statistically significant reduction in the duration of flu infection and a dose-related trend toward a reduction in symptom duration. — These results support the further clinical development of INNA-051 to mitigate the impact of natural infection by respiratory viruses such as SARS-CoV-2 and its variants: influenza, RSV, and the […]
Read More